Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity

BACKGROUND AND OBJECTIVES: Certain demographic and clinical characteristics, including the use of some disease-modifying therapies (DMTs), are associated with severe acute respiratory syndrome coronavirus 2 infection severity in people with multiple sclerosis (MS). Comprehensive exploration of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson-Yap, Steve, Pirmani, Ashkan, Kalincik, Tomas, De Brouwer, Edward, Geys, Lotte, Parciak, Tina, Helme, Anne, Rijke, Nick, Hillert, Jan A., Moreau, Yves, Edan, Gilles, Sharmin, Sifat, Spelman, Tim, McBurney, Robert, Schmidt, Hollie, Bergmann, Arnfin B., Braune, Stefan, Stahmann, Alexander, Middleton, Rod M., Salter, Amber, Bebo, Bruce, Van der Walt, Anneke, Butzkueven, Helmut, Ozakbas, Serkan, Boz, Cavit, Karabudak, Rana, Alroughani, Raed, Rojas, Juan I., van der Mei, Ingrid A., Sciascia do Olival, Guilherme, Magyari, Melinda, Alonso, Ricardo N., Nicholas, Richard S., Chertcoff, Anibal S., de Torres, Ana Zabalza, Arrambide, Georgina, Nag, Nupur, Descamps, Annabel, Costers, Lars, Dobson, Ruth, Miller, Aleisha, Rodrigues, Paulo, Prčkovska, Vesna, Comi, Giancarlo, Peeters, Liesbet M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423711/
https://www.ncbi.nlm.nih.gov/pubmed/36038263
http://dx.doi.org/10.1212/NXI.0000000000200021

Ejemplares similares

Ejemplares similares